Candida auris: A systematic review and meta‐analysis of current updates on an emerging multidrug‐resistant pathogen - Osei Sekyere - 2018 - MicrobiologyOpen - Wiley Online Library
Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values | Antimicrobial Agents and Chemotherapy
C. auris strains were collected from Montefiore Medical Center (MMC)... | Download Scientific Diagram
![PDF] First reported case of multidrug-resistant Candida auris in Canada. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ae0bea639831fb9878b2b64c7718e62901286483/2-Table1-1.png "PDF] First reported case of multidrug-resistant Candida auris in Canada. | Semantic Scholar")
PDF] First reported case of multidrug-resistant Candida auris in Canada. | Semantic Scholar
Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values | Antimicrobial Agents and Chemotherapy
Identification and antifungal drug susceptibility pattern of Candida auris in India Deshkar S, Patil N, Amberkar S, Lad A, Siddiqui F, Sharan S - J Global Infect Dis
Frontiers | Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris
Candida auris: MDR Fungus Among Us
AST News Update 2019 Practical Tips 1: AST For Candida Species
Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait | PLOS ONE
Antifungal Susceptibility Data for 54 Candida auris Isolates | Download Table
Summary of susceptibility testing of Candida auris isolate from the... | Download Table
Modulation of key antioxidant enzymes and cell cycle arrest as a possible antifungal mode of action of cinnamaldehyde based azole derivative - ScienceDirect
Frontiers | Nine Things Genomics Can Tell Us About Candida auris
Clinical, microbiological, and genomic characteristics of clade-III Candida auris colonization and infection in southern California, 2019–2022 | Infection Control & Hospital Epidemiology | Cambridge Core
Clinical, microbiological, and genomic characteristics of clade-III Candida auris colonization and infection in southern California, 2019–2022 | Infection Control & Hospital Epidemiology | Cambridge Core
Frontiers | Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris
In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris | bioRxiv
Candida auris: Diagnostic Challenges and Emerging Opportunities for the Clinical Microbiology Laboratory | SpringerLink
Frontiers | Nine Things Genomics Can Tell Us About Candida auris
Candida auris Isolates Resistant to Three Classes of Antifungal Medications — New York, 2019
Comparison between CDC-suggested tentative MIC breakpoints and... | Download Scientific Diagram
MIC50, MIC90, MIC range and geometric mean of five antifungal agents... | Download Scientific Diagram
